Skip to main content
. Author manuscript; available in PMC: 2014 Jul 25.
Published in final edited form as: Nat Rev Genet. 2012 Jul 10;13(8):537–551. doi: 10.1038/nrg3240

Table 3.

GWAS findings for psychiatric disorders.

Phenotype SNP Location Discovery GWAS Largest meta-analysis P value OR Nearest gene
AD rs3818361 chr1:207784968 2018/532434 <19870/3984635 3.7×10−14 1.18 CR1
AD rs744373 chr2:127894615 3006/14642193 <19870/3984635 2.6×10−14 1.17 BIN1
AD rs9349407 chr6:47453378 8309/736636 18762/2982736 8.6×10−9 1.11 CD2AP
AD rs11767557 chr7:143109139 8309/736636 18762/3559736 6.0×10−10 1.11 EPHA1
AD rs11136000 chr8:27464519 3941/784833 8371/26965193 1.6×10−16 1.18 CLU
AD rs610932 chr11:59939307 6688/1325135 >19000/3800035 1.2×10−16 1.10 MS4A cluster
AD rs3851179 chr11:85868640 3941/784933 8371/26966193 3.2×10−12 1.15 PICALM
AD rs3764650 chr19:1046520 5509/1153135 >17000/3400035 5.0×10−21 1.23 ABCA7
AD rs2075650 chr19:45395619 - 8371/26966193 1×10−295 2.53 APOE, TOMM40
AD rs3865444 chr19:51727962 8309/736636 18762/2982736 1.6×10−9 1.10 CD33
ALCcon rs1229984 chr4:100239319 -101 - 1.3×10−11 - ADH1B
ALCcon rs6943555 chr7:69806023 -100 - 4.1×10−9 - AUTS2
ALCcon rs671 chr12:112241766 -99 - 3×10−211 - ALDH2
BIP rs12576775 chr11:79077193 7481/925159 11974/5179359 4.4×10−8 1.14 ODZ4
BIP rs4765913 chr12:2419896 7481/925059 11974/5179259 1.5×10−8 1.14 CACNA1C
BIP rs1064395 chr19:19361735 682/1300194 8441/35362194 2.1×10−9 1.17 NCAN
NDsc rs3025343 chr9:136478355 41,27892 64,92492 3.6×10−8 1.13 DBH
NDcon rs1329650 chr10:93348120 38,18192 73,85392 5.7×10−10 - LOC100188947
NDint rs6265 chr11:27679916 74,03592 143,02392 1.8×10−8 0.94 BDNF
NDcon rs1051730 chr15:78894339 38,18192 73,85392 2.8×10−73 - CHRNA3
NDcon rs3733829 chr19:41310571 38,18192 73,85392 1.0×10−8 - EGLN2, CYP2A6
SCZ rs1625579 chr1:98502934 9394/1246258 17839/3385958 1.6×10−11 1.12 MIR137
SCZ rs2312147 chr2:58222928 - 18206/42536195 1.9×10−9 1.09 VRK2
SCZ rs1344706 chr2:185778428 479/2937174 18945/38675196 2.5×10−11 1.10 ZNF804A
SCZ rs17662626 chr2:193984621 9394/1246358 17839/3386058 4.6×10−8 1.20 PCGEM1
SCZ rs13211507 chr6:28257377 3322/358769 18206/42536195 1.4×10−13 1.22 MHC
SCZ rs7004635 chr8:3360967 9394/1246558 17839/3386258 2.7×10−8 1.10 MMP16
SCZ rs10503253 chr8:4180844 9394/1246458 17839/3386158 4.1×10−8 1.11 CSMD1
SCZ rs16887244 chr8:38031345 3750/646867 8133/1100767 1.3×10−10 1.19 LSM1
SCZ rs7914558 chr10:104775908 9394/1246658 17839/3386358 1.8×10−9 1.10 CNNM2
SCZ rs11191580 chr10:104906211 9394/1246758 17839/3386458 1.1×10−8 1.15 NT5C2
SCZ rs11819869 chr11:46560680 1169/3714197 3738/7802197 3.9×10−9 1.25 AMBRA1
SCZ rs12807809 chr11:124606285 - 18206/42536195 2.8×10−9 1.12 NRGN
SCZ rs12966547 chr18:52752017 9394/1246858 17839/3386558 2.6×10−10 1.09 CCDC68
SCZ rs9960767 chr18:53155002 - 18206/42537195 4.2×10−9 1.20 TCF4
SCZ+BIP rs1344706 chr2:185778428 479/2937174 21274/38675196 4.1×10−13 1.11 ZNF804A
SCZ+BIP rs2239547 chr3:52855229 9394/1247158 16374/1404658 7.8×10−9 1.12 ITIH3-ITIH4
SCZ+BIP rs10994359 chr10:62222107 9394/1247058 16374/1404558 2.4×10−8 1.22 ANK3
SCZ+BIP rs4765905 chr12:2349584 9394/1246958 16374/14044 7.0×10−9 1.11 CACNA1C

Table 3 focuses on results achieving genome-wide significance in large samples. We use a significance threshold of 5×10−8 (reference 198). Most associations achieving this level of significance are secure but some may ultimately prove not to be. Included are SNPs with p < 5×10−8 that were evaluated in samples of a minimum of around 10,000 cases and 10,000 controls. Discovery sample sizes reflect the primary samples for which full GWAS were conducted. In most cases, discovery P values were > 5×10−8 but met a threshold (typically 1×10−5) for inclusion in replication efforts. In some instances, simultaneous publications based upon overlapping samples were considered “discovery”. Where this occurred, providing samples of roughly equivalent sizes, the most significant primary GWAS findings are given; otherwise, the largest discovery samples are favored. For many studies, it was not possible to extract the exact sample size used for each locus so the sample sizes above are approximate. P-values and ORs are from the meta-analysis with the largest sample sizes. If two meta-analyses based on overlapping samples reported similar results, the “discovery” study is cited. The genes nearest each locus are provided but etiological variants are generally unknown, and it remains likely that some of the associations do not alter the function of the designated genes (e.g., ITIH3-ITIH4 where multiple correlated SNPs span many genes, and TCF4-CCDC68 where statistically independent associations occur in TCF4 and closer to CCDC68). In the TCF4-CCDC68 example, it may be that both associations point to the same functional element but, it is also possible that independent etiological variants occur in adjacent genes.

For the SCZ loci attributed to Steinberg et al., 195 no discovery sample size is listed because the initial P values were modest and, as the authors conducted multiple follow-up analyses, there is no obvious discovery sample. At the MHC, the International Schizophrenia Consortium 69 is designated discovery as it was the only primary GWAS for which genome-wide significance at the MHC was obtained. Steinberg et al. is cited for the meta-analysis at the MHC as it reported the most significant MHC association. 195 The most significant SNP at the MHC across the two studies is not identical, and the one listed is that from Steinberg et al. Multiple statistically independent SNPs have been reported at the MHC. 58,186 We note that genome-wide significance had been reported in BIP for ANK3199 but not in a larger mega-analysis including the same samples. 59 Others have reported genome-wide significance for composite phenotype studies of ITIH3-ITIH4200 (but see reference 201) and CACNA1C 202 but in samples smaller than required for inclusion in the above table.

ALCcon means alcohol consumption. The rs671 association was in East Asian samples. The ADH1B locus was also associated with ALC.

NDcon means nicotine consumption (as maximal cigarettes per day, continuous). NDinit means smoking initiation (ever versus never began smoking). NDsc means smoking cessation (whether regular smokers had quite at time of interview).